Literature DB >> 23407605

A patient with repeated catastrophic multi-vessel coronary spasm after zotarolimus-eluting stent implantation.

Shi Hyun Rhew1, Youngkeun Ahn, Eun Ae Cho, Min Sok Kim, Su Young Jang, Ki Hong Lee, Min Goo Lee, Keun Ho Park, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Myung Ho Jeong.   

Abstract

Drug-eluting stents (DES) have gained great popularity because of extraordinarily low rates of restenosis. Despite these superior clinical outcomes, several cases regarding the severe multi-vessel coronary spasm, although rare, after the placement of first generation DES have been reported. We report a case of severe, multi-vessel coronary spasm that occurred two occasions after placement of a zotarolimus-eluting stent, one of the second generation DES, in a 42-year-old man with unstable angina. The first incidence was relieved by intracoronary nitroglycerin alone, and second incident, which had combined fixed stenosis was treated with intracoronary nitroglycerin and everolimus-eluting stent.

Entities:  

Keywords:  Coronary vessels; Drug-eluting stents; Spasm

Year:  2013        PMID： 23407605      PMCID： PMC3569567          DOI： 10.4070/kcj.2013.43.1.48

Source DB:  PubMed          Journal:  Korean Circ J        ISSN： 1738-5520            Impact factor:   3.243


  25 in total

1.  Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Authors:  Giovanna Sarno; Bo Lagerqvist; Jörg Carlsson; Göran Olivecrona; Johan Nilsson; Fredrik Calais; Matthias Götberg; Tage Nilsson; Iwar Sjögren; Stefan James
Journal:  Int J Cardiol       Date:  2012-01-13       Impact factor: 4.164

Review 2.  Vasoconstriction and coronary artery spasm after drug-eluting stent placement.

Authors:  Mario Togni; Franz R Eberli
Journal:  J Invasive Cardiol       Date:  2006-12       Impact factor: 2.022

Review 3.  Severe, diffuse coronary artery spasm after drug-eluting stent placement.

Authors:  Brigitta C Brott; Andreas S Anayiotos; Gregory D Chapman; Peter G Anderson; William B Hillegass
Journal:  J Invasive Cardiol       Date:  2006-12       Impact factor: 2.022

Review 4.  Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.

Authors:  Yoshiki Kusama; Eitaro Kodani; Akihiro Nakagomi; Toshiaki Otsuka; Hirotsugu Atarashi; Hiroshi Kishida; Kyoichi Mizuno
Journal:  J Nippon Med Sch       Date:  2011       Impact factor: 0.920

5.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

6.  Comparison of clinical and laboratory findings between patients with diffuse three-vessel coronary artery spasm and other types of coronary artery spasm.

Authors:  K K Koh; T H Moon; J H Song; G S Park; K H Lee; S K Cho; S S Kim
Journal:  Cathet Cardiovasc Diagn       Date:  1996-02

7.  Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina.

Authors:  T Motoyama; H Kawano; K Kugiyama; O Hirashima; M Ohgushi; R Tsunoda; Y Moriyama; Y Miyao; M Yoshimura; H Ogawa; H Yasue
Journal:  J Am Coll Cardiol       Date:  1998-11-15       Impact factor: 24.094

Review 8.  Polymer coatings and delayed arterial healing following drug-eluting stent implantation.

Authors:  R A Byrne; M Joner; A Kastrati
Journal:  Minerva Cardioangiol       Date:  2009-10       Impact factor: 1.347

9.  N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.

Authors:  Taek Geun Kwon; Jang Ho Bae; Myung Ho Jeong; Young Jo Kim; Seung Ho Hur; In Whan Seong; Myeong Chan Cho; Ki Bae Seung; Yang Soo Jang; Seung Jung Park
Journal:  Int J Cardiol       Date:  2008-02-20       Impact factor: 4.164

10.  Endothelial cell recovery between comparator polymer-based drug-eluting stents.

Authors:  Michael Joner; Gaku Nakazawa; Aloke V Finn; Shawn Chin Quee; Leslie Coleman; Eduardo Acampado; Patricia S Wilson; Kristi Skorija; Qi Cheng; Xin Xu; Herman K Gold; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094
View more
  3 in total

1.  Coronary vasomotion dysfunction after everolimus-eluting stent implantation.

Authors:  Pietro Giudice; Tiziana Attisano; Marco Di Maio; Elisabetta M Bellino; Maria V Polito; Cesare Baldi; Francesco Vigorito; Michele R Di Muro; Salvatore D Tomasello; Alfredo R Galassi; Federico Piscione
Journal:  Interv Med Appl Sci       Date:  2014-12-22

2.  Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.

Authors:  Paul Zarogoulidis; Kaid Darwiche; Kosmas Tsakiridis; Helmut Teschler; Lonny Yarmus; Konstantinos Zarogoulidis; Lutz Freitag
Journal:  J Mol Genet Med       Date:  2013-08-26

Review 3.  Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Georgia Pitsiou; Bernd Linsmeier; Drosos Tsavlis; Ioannis Kioumis; Eleni Papadaki; Lutz Freitag; Theodora Tsiouda; J Francis Turner; Robert Browning; Michael Simoff; Nikolaos Sachpekidis; Kosmas Tsakiridis; Bojan Zaric; Lonny Yarmus; Sofia Baka; Grigoris Stratakos; Harald Rittger
Journal:  J Cancer       Date:  2016-01-13       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.